TRACI KREIFELS: Open Payments
NPI 1578057071 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 64 payments from 13 companies in 2025. Trend: 2023 $1,508 · 2024 $1,359 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $187 |
| Novo Nordisk Inc | 10 | $184 |
| ABBVIE INC. | 12 | $181 |
| Lilly USA, LLC | 8 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $102 |
| Astellas Pharma US Inc | 3 | $97 |
| Corcept Therapeutics | 2 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Amgen Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
Products named: Ozempic, NURTEC ODT, QULIPTA, JARDIANCE, Veozah, Korlym, LEQVIO, MOUNJARO.
Industry payments across NE — which companies pay providers there.
